Jan 5, 2026 · A biosimilar is not considered a “generic” in the same way that a traditional, small molecule drug (for example: ibuprofen or acetaminophen) is determined to be a generic. Biosimilars are …

Dec 19, 2025 · Is there a list of all biosimilars approved in the United States? There have been 81 biosimilars approved by the U.S. Food and Drug Administration (FDA). The most recent biosimilar …

Jun 24, 2025 · Steqeyma is an interchangeable biosimilar to Stelara used to treat Crohn's disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic arthritis.

Apr 2, 2025 · Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with chemotherapy. Includes Zarxio side effects, interactions and indications.

Oct 10, 2025 · An interchangeable biosimilar is a biologic product that can be automatically substituted for the reference product (in this case, Eylea) by your pharmacist, depending upon state laws. Your …

May 2, 2025 · Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as rheumatoid arthritis and polyangiitis. It is given by IV …

Jun 3, 2025 · Yesintek is an interchangeable biosimilar to Stelara used to treat plaque psoriasis, active psoriatic arthritis, or moderately to severely active Crohn's disease or ulcerative colitis in adults.

May 29, 2024 · Jubbonti Biosimilars Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product. …

Aug 12, 2024 · The biosimilars of Herceptin are Herzuma, Kanjinti, Ogivri, Ontruzant and Trazimera What does ‘interchangeable product’ mean? An interchangeable biosimilar is a biosimilar medicine …

Apr 4, 2025 · Tyenne (tocilizumab-aazg) gained FDA approval on March 5, 2024, and is a biosimilar to Actemra (tocilizumab) with both subcutaneous and IV formulations. A biosimilar is a biological …